# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-105927
Filing Date
2025-11-04
Accepted
2025-11-04 07:39:10
Documents
41
Period of Report
2025-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2530124d1_8k.htm iXBRL | 8-K | 26670
2 | EXHIBIT 99.1 | tm2530124d1_ex99-1.htm | EX-99.1 | 165617
3 | EXHIBIT 99.2 | tm2530124d1_ex99-2.htm | EX-99.2 | 38601
7 | GRAPHIC | tm2530124d1_ex99-1img01.jpg | GRAPHIC | 2830
8 | GRAPHIC | tm2530124d1_ex99-2img001.jpg | GRAPHIC | 212016
9 | GRAPHIC | tm2530124d1_ex99-2img002.jpg | GRAPHIC | 507307
10 | GRAPHIC | tm2530124d1_ex99-2img003.jpg | GRAPHIC | 215112
11 | GRAPHIC | tm2530124d1_ex99-2img004.jpg | GRAPHIC | 153961
12 | GRAPHIC | tm2530124d1_ex99-2img005.jpg | GRAPHIC | 198207
13 | GRAPHIC | tm2530124d1_ex99-2img006.jpg | GRAPHIC | 126387
14 | GRAPHIC | tm2530124d1_ex99-2img007.jpg | GRAPHIC | 190944
15 | GRAPHIC | tm2530124d1_ex99-2img008.jpg | GRAPHIC | 177669
16 | GRAPHIC | tm2530124d1_ex99-2img009.jpg | GRAPHIC | 116919
17 | GRAPHIC | tm2530124d1_ex99-2img010.jpg | GRAPHIC | 197698
18 | GRAPHIC | tm2530124d1_ex99-2img011.jpg | GRAPHIC | 199684
19 | GRAPHIC | tm2530124d1_ex99-2img012.jpg | GRAPHIC | 270958
20 | GRAPHIC | tm2530124d1_ex99-2img013.jpg | GRAPHIC | 254296
21 | GRAPHIC | tm2530124d1_ex99-2img014.jpg | GRAPHIC | 174291
22 | GRAPHIC | tm2530124d1_ex99-2img015.jpg | GRAPHIC | 247648
23 | GRAPHIC | tm2530124d1_ex99-2img016.jpg | GRAPHIC | 252539
24 | GRAPHIC | tm2530124d1_ex99-2img017.jpg | GRAPHIC | 172142
25 | GRAPHIC | tm2530124d1_ex99-2img018.jpg | GRAPHIC | 212714
26 | GRAPHIC | tm2530124d1_ex99-2img019.jpg | GRAPHIC | 141605
27 | GRAPHIC | tm2530124d1_ex99-2img020.jpg | GRAPHIC | 157506
28 | GRAPHIC | tm2530124d1_ex99-2img021.jpg | GRAPHIC | 174869
29 | GRAPHIC | tm2530124d1_ex99-2img022.jpg | GRAPHIC | 158021
30 | GRAPHIC | tm2530124d1_ex99-2img023.jpg | GRAPHIC | 108252
31 | GRAPHIC | tm2530124d1_ex99-2img024.jpg | GRAPHIC | 117645
32 | GRAPHIC | tm2530124d1_ex99-2img025.jpg | GRAPHIC | 54120
33 | GRAPHIC | tm2530124d1_ex99-2img026.jpg | GRAPHIC | 174612
| Complete submission text file | 0001104659-25-105927.txt |  | 7229686

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | fold-20251104.xsd | EX-101.SCH | 3044
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | fold-20251104_lab.xml | EX-101.LAB | 34239
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | fold-20251104_pre.xml | EX-101.PRE | 22378
43 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2530124d1_8k_htm.xml | XML | 3552

Mailing Address 47 HULFISH STREET PRINCETON NJ 08542
Business Address 47 HULFISH STREET PRINCETON NJ 08542 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 251446477
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)